Evidence map›Paper›PMID 41697281›Full record

ReviewChirurgie (Heidelberg, Germany)2026

[Diagnostics and treatment of pheochromocytomas and paragangliomas].

Pier Francesco Alesina, Polina Knyazeva

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pier Francesco AlesinaKlinik für Chirurgie, Zentrum für Endokrine und Onkologische Chirurgie, Evang. Kliniken Essen-Mitte, Henricistr. 92, 45136, Essen, Deutschland. p.alesina@kem-med.com.ORCID http://orcid.org/0000-0002-8508-9934
Polina KnyazevaKlinik für Endokrine Chirurgie, Helios Universitätsklinikum Wuppertal, Wuppertal, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors arising from chromaffin cells and are capable of producing catecholamines. The diagnostics rely on measurements of free plasma and urinary fractionated metanephrines, complemented by computed tomography (CT) or magnetic resonance imaging (MRI) for anatomical imaging. Up to 35% of PPGLs are hereditary and the underlying genetic background significantly influences both tumor biology and surgical strategy. Surgery remains the cornerstone of treatment. For adrenal tumors, laparoscopic or retroperitoneoscopic adrenalectomy represents the standard of care, while minimally invasive approaches are also feasible for many paragangliomas. Preoperative blood pressure optimization is essential, although the routine use of an alpha-blockade is increasingly questioned. Organ-preserving tumor extirpation should be considered whenever oncologically safe, particularly in patients with hereditary syndromes, bilateral tumors and younger age, in order to avoid postoperative adrenal insufficiency.

Indexed as

AdrenalectomyAdrenal Gland NeoplasmsParagangliomaPheochromocytomaHumansLaparoscopyMagnetic Resonance ImagingTomography, X-Ray ComputedAdrenalectomyCortical-sparing adrenalectomyLaparoscopic adrenalectomyPreoperative blood pressure optimizationRetroperitoneoscopic adrenalectomy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.